Kelly Hwang is a partner of the firm. She has over 20 years of experience in all aspects of IP including patent procurement, post-grant proceedings, clearance opinions, due diligence, as well as pharmaceutical patent litigation brought under the Hatch-Waxman Act. Kelly is one of the leaders in both chemical and pharmaceutical technology teams of Lerner David.
Technically and Legally Savvy
Based on her track record of obtaining favorable outcomes, clients frequently trust Kelly with the most difficult cases. Her success, in part, comes from her ability to convey complex technologies and legal issues in a simple and straightforward manner, and her creative legal solutions. Her skills in explaining technology arise, in part, from her work as an engineer in the chemical/mechanical industry for over 4 years. She is also a first named inventor of a U.S. patent based on her work as an engineer.
Kelly is fluent in Korean and Japanese. She makes frequent trips to Asia to advise the firm’s Asia-based clients on U.S. patent and trademark law. She is knowledgeable about the programs available at patent offices around the world and assists clients in creating a valuable global patent portfolio in a cost efficient manner. Her object is to craft quality patent portfolios and provide innovative IP legal strategies to add value to clients’ global IP assets. Kelly manages numerous IP portfolios for various multinational corporations. Kelly also works with many of the attorneys to help them formulate arguments to effectively address issues raised by the examiners worldwide. Kelly’s efforts have contributed to Lerner David being a top firm in the technology centers focusing on chemical and materials engineering related inventions at the U.S. Patent Office.
Kelly creates and implements dynamic IP strategies based on a careful listening to client’s concerns and goals and clearly communicating risks and benefits on strategic options to the clients. Kelly respects the expertise that a client brings to the legal analysis and includes a client’s non-legal considerations as part of the legal counseling. In doing so, she provides a solution which meets the client’s short term and long term goals.
Kelly Hwang is a partner of the firm. She has over 16 years of experience in all aspects of IP including patent procurement, post-grant proceedings, clearance opinions, due diligence, as well as pharmaceutical patent litigation brought under the Hatch-Waxman Act. Kelly is one of the leaders in both chemical and pharmaceutical technology teams of Lerner David.
Post-Grant Proceedings (IPR, PGR...)
Due Diligence, Mergers and Acquisitions
IP Asset Management
Trademark and Trade Dress Procurement
2004, New York
2002, New Jersey
2002, United States Patent & Trademark Office
J.D., Rutgers Law School-Newark, 2002; Managing Editor, Rutgers Computer and Technology Law Journal
B.E., Chemical Engineering, Cooper Union School of Engineering, 1995; (four-year, full-tuition scholarship)
On January 27, 2014, Lerner David won a complete victory for our client, LG Chem, in an Inter Partes Review filed by Ube Maxell Co., Ltd. against LG Chem's U.S. Patent No. 7,709,152. Ube Maxell challenged the '152 Patent as anticipated and obvious on more than six different grounds. The Patent Trial and Appeal Board relied on Lerner David's arguments in a Preliminary Response as to why Ube Maxell's prior art references were deficient to show unpatentability of LG Chem's ‘152 Patent. Accordingly, the PTAB denied Ube Maxell's petition as to all challenged claims and ordered that no IPR trial be instituted.
Patent Law Externship Program Welcomes Students from Rutgers and UPenn
2022 Year-in-Review: U.S. Patent Law
Hwang, Chernoff and Caro-Esposito are Panelists in the Christiana Foglio DC’84 Douglass Career Conference for Women
Hwang Presented at the Annual Christiana Foglio’84 Douglass Career Conference for Women
BIOTECHNOLOGY SEQUENCE COMPLIANCE - USPTO PatentIn 3.5 Software Training and Hints for Compliance with ST.25 - What Businesses Need to Know
Hwang speaks at Asian Patent Attorney Association (APAA)’s 50th Anniversary Celebration Seminar
Lerner David Partners Presenting at Upcoming ACI's Hatch Waxman Series: Paragraph IV Disputes Conference
Lerner David Supports New Jersey Law Firm Night at Rutgers Law School Newark
Lerner David Sponsors New Jersey Women Lawyer's Association 11th Annual Gala
Hwang Presents at the NJ Women Lawyers Association
Lerner David at Rutgers-Newark Law's NJ Law Firm Night
Lerner David Recognized by IAM Patent 1000: The World’s Leading Patent Professionals 2023
Lerner David Achieves Mansfield Rule Certification for Midsize Firms
Hwang Named as one of NJBIZ’s 2023 Leaders in Law Honorees
Lerner David Ranks Among Top 10 Patent Firms in TC 1700 and TC 3700
Lerner David Recognized by IAM Patent 1000: The World’s Leading Patent Professionals 2022
Lerner David Ranks Top 3 in TC 3700 and Top 6 in TC 1700
Lerner David Welcomed Two Rutgers Students for Externship Program
Lerner David Participating in Midsize Mansfield Rule
Lerner David Has Been Named a Winner Under 5 Categories as the New Jersey Law Journal Announced Its 2020 Professional Excellence Winners
Kelly Hwang Selected as a Top 25 Leading Woman Entrepreneur, Intrapreneur, Socialpreneur or Brand Builder 2020 Winner
Lerner David Named a Top Patent Firm in TC 3700
Hwang Named as Finalist for Minority Female US Lawyer of the Year
Lerner David Achieves Top 20 Ranking on Juristat’s “Top 100 Patent Firms” List
Lerner David Named a Top Patent Firm in TC 1700
Lerner David Receives Top Honors in New Jersey For Intellectual Property Litigation
Lerner David's 2014 Super Lawyers
Lerner David Hits Top 40 Patent Law Firm
Korean and Japanese